Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

Malkin, C J, Pugh, P J, Morris, P D, Kerry, K E, Jones, R D, Jones, T H, Channer, K S·2004·Heart

Cited by (250)

Items 101–200 of 250

  1. Role of Testosterone in the Treatment of Cardiovascular Disease
    Carolyn M. Webb, Peter D. Collins · 2017 · European Cardiology Review
  2. Testim® 1% testosterone gel for the treatment of male hypogonadism
    Pierre Marc Bouloux · 2005 · Clinical Therapeutics
  3. Testosterone inhibits aneurysm formation and vascular inflammation in male mice
    Bo‐Kyung Son, Taro Kojima, Sumito Ogawa, Masahiro Akishita · 2019 · Journal of Endocrinology
  4. Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta‐analysis and systematic review
    Zhen Chang Liang, Jun Wei Zhu, Xiaoxin Duo, Shangheng Shi, Yawei Xu, Yongjiao Yang, Rui Hu, Yi Lu, Wei Zhang, Ningjing Ou et al. · 2019 · Andrology
  5. Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II
    Abdulmaged M. Traish · 2014 · Steroids
  6. Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    Al Baha Barqawi, E. David Crawford · 2005 · International Journal of Impotence Research
  7. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis
    Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, Valeria Carinci, Gianni Casella, Linda Vignozzi, Alessandra Sforza, Mario Maggi · 2024 · Expert Opinion on Drug Safety
  8. Mechanisms in endocrinology: hypogonadism and metabolic health in men—novel insights into pathophysiology
    Clare Miller, Lauren Madden-Doyle, Channa Nalin Jayasena, Marie McIlroy, Mark Sherlock, Michael O’Reilly · 2024 · European Journal of Endocrinology
  9. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
    Mustafa Mohamed Alwani, Aksam A Yassin, Raidh A. Talib, Ahmad Rajeh Al-Qudimat, Omar M. Aboumarzouk, Raed M. Al‐Zoubi, Farid Saad, Karim Sultan Haider, Abdulla Al Ansari · 2021 · Vascular Health and Risk Management
  10. Cardiovascular effect of testosterone replacement therapy in aging male.
    Davide Francomano, Roberto Bruzziches, Marco Natali, Antônio Aversa, Giovanni Spera · 2010 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
  11. Physiologic Testosterone Therapy has no Effect on Serum Levels of Tumour Necrosis Factor-α in Men with Chronic Heart Failure
    Peter John Pugh, Richard D. Jones, Chris J. Malkin, Joanne Hall, Joanne E. Nettleship, K Kerry, T. Hugh Jones, Kevin Stephen Channer · 2005 · Endocrine Research
  12. Androgen supplementation improves some but not all aspects of immune senescence in aged male macaques
    Maham Rais, Randall M. Wilson, Henryk F. Urbanski, Ilhem Messaoudi · 2017 · GeroScience
  13. Cardiovascular and metabolic actions of the androgens: Is testosterone a Janus-faced molecule?
    John N. Stallone, Ahmed Kolade Oloyo · 2022 · Biochemical Pharmacology
  14. Male hormonal contraception: Potential risks and benefits
    Niloufar Ilani, Ronald S. Swerdloff, Christina Wang · 2011 · Reviews in Endocrine and Metabolic Disorders
  15. All-cause Mortality and Mortality of Myocardial Infarction for 989 Legally Castrated Men
    Finn Edler von Eyben, Christian L Graugaard, Michael Væth · 2005 · European Journal of Epidemiology
  16. Review of Testim® gel
    Tom McNicholas, Teng Aik Ong · 2006 · Expert Opinion on Pharmacotherapy
  17. Testosterone and Coronary Artery Disease
    Monica Schwarcz, William H. Frishman · 2010 · Cardiology in Review
  18. Testosterone Replacement Therapy and Components of the Metabolic Syndrome
    James E. Anaissie, Natalie H. Roberts, Ping Wang, Faysal A. Yafi · 2017 · Sexual Medicine Reviews
  19. Age-associated (cardio)metabolic diseases and cross-talk between adipose tissue and skeleton: endocrine aspects
    Silvia Migliaccio, Emanuela Alessandra Greco, Antônio Aversa, Andrea Lenzi · 2014 · Hormone Molecular Biology and Clinical Investigation
  20. Testosterone replacement therapy and cardiovascular risk factors modification
    Elie J Chahla, Mireille El Hayek, John Edward Morley · 2011 · The Aging Male
  21. Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer
    Chi‐Fai Ng, Jeremy Yuen‐Chun Teoh, Samson Yun Sang Chan, PeterKF Chiu, Darren M.C. Poon, Ho-Yuen Cheung, SimonSM Hou · 2014 · Asian Journal of Andrology
  22. Sex steroids and cardiovascular disease
    Bu Beng Yeap · 2014 · Asian Journal of Andrology
  23. Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus
    L. Yu. Morgunov, И. А. Денисова, T. I. Rozhkova, Ludmila V. Stakhovskaya, Veronika Igorevna Skvortsova · 2018 · The Aging Male
  24. Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
    Abraham Morgentaler, Sandeep Dhindsa, Adrian Sandra Dobs, Geoff Ian Hackett, Thomas Hugh Jones, Robert Alan Kloner, Martin M. Miner, Michael Zitzmann, Abdulmaged M. Traish · 2024 · Mayo Clinic Proceedings
  25. Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management
    Shin‐ichi Hisasue · 2015 · International Journal of Urology
  26. Testosterone therapy and cardiovascular risk
    James P. Walsh, Anne C. Kitchens · 2014 · Trends in Cardiovascular Medicine
  27. Testosterone and cardiovascular disease – the controversy and the facts
    Abraham Morgentaler, Allison H. Feibus, Neil H Baum · 2015 · Postgraduate Medicine
  28. Review: Testosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure
    Jesse J. Naghi, Kiran J. Philip, Deanna Dilibero, Robert Willix, Ernst R. Schwarz · 2010 · Journal of Cardiovascular Pharmacology and Therapeutics
  29. Sex Hormones and Androgen Receptor: Risk Factors of Coronary Heart Disease in Elderly Men
    Jian Jing Cao, Hui Zou, Bingpo Zhu, Hao Wang, Jian Li, Yu Ding, Xiao-ying Li · 2010 · Chinese Medical Sciences Journal
  30. QSAR models for anti-androgenic effect – a preliminary study
    Gunde Egeskov Jensen, Nikolai Georgiev Nikolov, Eva Bay Wedebye, Tine Ringsted, Jay Russell Niemelä · 2011 · SAR and QSAR in environmental research
  31. Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research
    Michael Zitzmann, Giulia Rastrelli, Robert Douglas Murray, David A. Edwards, Yacov Reisman, Preethi Mohan Rao, Alexander Sahi, Thomas Hugh Jones, Alberto Ferlin, Eleni Armeni et al. · 2025 · Andrology
  32. Risk of acute myocardial infarction after androgen‐deprivation therapy for prostate cancer in a Chinese population
    Jeremy Yuen‐Chun Teoh, Samson Yun Sang Chan, Peter Ka‐Fung Chiu, Darren M.C. Poon, Ho-Yuen Cheung, Simon S.M. Hou, Chi‐Fai Ng · 2014 · British Journal of Urology
  33. Testosterone replacement therapy and cardiovascular disease
    Jeremy M. Auerbach, Mohit Khera · 2022 · International Journal of Impotence Research
  34. Testicular Dysfunction in Systemic Diseases
    Gideon A. Sartorius, David J. Handelsman · 2010 · Springer eBooks
  35. Testosterone replacement therapy in hypogonadal male patients with hypogonadism and heart failure: a meta-analysis of randomized controlled studies
    Rossella Cannarella, Federica Barbagallo, Andrea Crafa, Laura M. Mongioì, Antônio Aversa, Emanuela Alessandra Greco, Rosita Angela Condorelli, Sandro La Vignera, Aldo Eugenio Calogero · 2022 · Minerva Urology and Nephrology
  36. Endogenous testosterone levels and cardiovascular disease in healthy men
    Kevin S Channer · 2011 · Heart
  37. An update on heart disease risk associated with testosterone boosting medications
    Giovanni Corona, Giulia Rastrelli, Federica Guaraldi, Gianfranco Tortorici, Yacov Reismann, Alessandra Sforza, Mario Maggi · 2019 · Expert Opinion on Drug Safety
  38. The role of retinol-binding protein 4 and its relationship with sex hormones in coronary artery disease
    Hongxia Wang, Ping Zhou, Dan Zou, Ying Liu, Xiang Lü, Zhengxia Liu · 2018 · Biochemical and Biophysical Research Communications
  39. The Effect of Testosterone on Cardiovascular Disease
    Jeannie J. Su, Samuel K. Park, Tung‐Chin Hsieh · 2014 · American Journal of Men s Health
  40. Androgens Ameliorate Impaired Ischemia-Induced Neovascularization Due to Aging in Male Mice
    Yuen Ting Lam, Laura Lecce, Sui Ching G. Yuen, Steven G. Wise, David J. Handelsman, Richard H. Karas, Martin K C Ng · 2019 · Endocrinology
  41. Novel androgen therapies including selective androgen receptor modulators
    Jung‐Woo Kang, Runzhi Chen, Tharu Tharakan, Suks Minhas · 2022 · Best Practice & Research Clinical Endocrinology & Metabolism
  42. Polymorphisms of steroid 5- α- reductase type I (SRD5A1) gene are associated to peripheral arterial disease
    Salvatore Santo Signorelli, Vincenza Barresi, Nicolò Musso, Massimiliano Anzaldi, Eleonora Croce, Valerio Fiore, D. F. Condorelli · 2008 · Journal of Endocrinological Investigation
  43. Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure
    John Saxton, Irena Zwierska, Atish Mathur, Kevin Stephen Channer · 2006 · BMC Cardiovascular Disorders
  44. Correlation between Iron Status Parameters and Hormone Levels in Women with Polycystic Ovary Syndrome
    Hussein Kadhem Al‐Hakeim · 2012 · Clinical Medicine Insights Women s Health
  45. Hormones and Cardiovascular Disease in Older Men
    Bu Beng Yeap, Leon A Flicker · 2014 · Journal of the American Medical Directors Association
  46. The mediatory role of androgens on sex differences in glucose homeostasis and incidence of type 2 diabetes: the KORA study
    Hamidreza Raeisi‐Dehkordi, Barbara Thorand, Sara Beigrezaei, Annette Peters, Wolfgang Rathman, Jerzy Adamski, Angéline Chatelan, Yvonne T. van der Schouw, Oscar H. Franco, Taulant Muka et al. · 2024 · Cardiovascular Diabetology
  47. Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
    Guilherme Renke, Francisco Tostes · 2023 · Pharmaceuticals
  48. Testosterone and the heart
    Geoffrey Ian Hackett · 2012 · International Journal of Clinical Practice
  49. Androgens and Coronary Artery Disease
    Fredrick C. W. Wu, Arnold von Eckardstein · 2003 · Humana Press eBooks
  50. Voluntary wheel running and testosterone replacement increases heart angiogenesis through miR-132 in castrated diabetic rats
    Leila Chodari, Hassan Dariushnejad, Vajihe Ghorbanzadeh · 2019 · Physiology International
  51. Testosterone Substitution: Current Modalities and Perspectives
    Michael Zitzmann, Eberhard Nieschlag · 2006 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  52. Testosterone Replacement Therapy and Cardiovascular Disease: Balancing Safety and Risks in Hypogonadal Men
    Kelli Blackwell, Michele Blackwell, Thomas Blackwell · 2023 · Current Cardiology Reports
  53. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea
    Young Hwii Ko, Je Jong Kim · 2011 · Asian Journal of Andrology
  54. Hipogonadismo, disfunción eréctil y disfunción endotelial en varones con infección por el virus de la inmunodeficiencia humana
    Óscar Moreno, Antonio Miguel Pico, Joaquín Portilla · 2009 · Medicina Clínica
  55. Effects of testosterone supplementation on clinical and rehabilitative outcomes in older men undergoing on-pump CABG
    Marcello Giuseppe Maggio, Francesco Nicolini, Chiara Cattabiani, Cesare Beghi, Tiziano Gherli, Robert S. Schwartz, Giorgio Valenti, Gian Paolo Ceda · 2012 · Contemporary Clinical Trials
  56. Erectile dysfunction and hypogonadism (low testosterone).
    Jack Barkin · 2011 · PubMed
  57. Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective
    Jeremy Yuen‐Chun Teoh, Chi‐Fai Ng · 2016 · International Urology and Nephrology
  58. Documento básico de consenso sobre el síndrome de hipogonadismo de inicio tardío
    Antonio Becerra Fernández, Luis Enríquez Acosta · 2008 · Endocrinología y Nutrición
  59. Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?
    Dimitri C. Cassimatis, Matthew T Crim, NANETTE KASS WENGER · 2016 · Current Treatment Options in Cardiovascular Medicine
  60. Current and emerging testosterone therapies for male hypogonadism
    Jed C. Kaminetsky, Blake Wynia · 2015 · Research and Reports in Endocrine Disorders
  61. Pharmacokinetics and Pharmacodynamics: The Role of Sex and Gender
    Flavia Franconi, Manuela Sanna, Elisabetta Straface, Roberto Chessa, Giuseppe M.C. Rosano · 2011 · Springer eBooks
  62. The Effect of Testosterone and Voluntary Exercise, Alone or Together, on miRNA-126 Expression Changes in Heart of Diabetic Rats
    Leila Chodari · 2017 · Acta Endocrinologica (Bucharest)
  63. Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism
    Jin Wook Kim, Du Geon Moon · 2011 · Korean journal of urology
  64. Testosterone in men's health: a new role for an old hormone
    Robert J. Feeley, Farid Saad, André T. Guay, Abdulmaged M. Traish · 2009 · Journal of Men s Health
  65. Testosterone and Men's Health
    James E. Anaissie, Alexander W. Pastuszak, Mohit Khera · 2019 · Elsevier eBooks
  66. Saúde masculina: tão negligenciada, principalmente pelos homens
    Ricardo M.R. Meirelles, Alexandre Hohl · 2009 · Arquivos Brasileiros de Endocrinologia & Metabologia
  67. The role of androgens in pressure overload myocardial hypertrophy
    Marie Schafstedde, Sarah Nordmeyer · 2023 · Frontiers in Endocrinology
  68. Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans.
    Spyros Kokolis, Jonathan D. Marmur, Luther T. Clark, John Kassotis, Rodamanthos Kokolis, Erdal Çavuşoğlu, Reuven Lapin, Sheldon Breitbart, Jason Lazar · 2006 · PubMed
  69. Effect of saponin extract of Glycyrrihiza glabra in activity of hepatic enzymes and some biochemical parameters in serum of adults ovariectomized female rats
    Ameera A. Hamdoon, Elham M. Al-Khashab, Hadeel M. Al-Hashemi · 2020 · Al-mağallaẗ al-ʻirāqiyyaẗ li-l-ʻulūm al-bayṭariyyaẗ/Iraqi journal of veterinary sciences
  70. Circulating Endothelial Cells as Marker of Endothelial Damage in Male Hypogonadism
    Domenico Milardi, Giuseppe Grande, Antonella Giampietro, Francesca Vendittelli, Sara Palumbo, Linda Tartaglione, Riccardo Marana, Alfredo Pontecorvi, Laura De Marinis, Cecilia Zuppi et al. · 2012 · Journal of Andrology
  71. Growth hormone and testosterone in heart failure therapy
    Megha Agarwal, Jesse J. Naghi, Kiran J. Philip, Anita Phan, Robert Willix, Ernst R. Schwarz · 2010 · Expert Opinion on Pharmacotherapy
  72. Hypogonadismus und infertilität bei systemischen Erkrankungen
    Gideon A. Sartorius, David J. Handelsman · 2009 · Springer eBooks
  73. IGF-1 levels are significantly correlated with patient-reported measures of sexual function
    Alexander W. Pastuszak, John S. Liu, Alok Vij, O Mohamed, Kumaran Sathyamoorthy, Larry I. Lipshultz, Mohit Khera · 2011 · International Journal of Impotence Research
  74. Effect of testosterone supplementation on nitroso‐redox imbalance, cardiac metabolism markers, and S100 proteins expression in the heart of castrated male rats
    Nadia Regouat, A. Cheboub, M. Benahmed, A. Belarbi, Fatima Hadj-Bekkouche · 2017 · Andrology
  75. Testosterone replacement therapy
    T. Hugh Jones · 2007 · British Journal of Hospital Medicine
  76. Cross‐sectional analysis of testosterone therapies in hypopituitary men on stable pituitary hormone replacement
    Sajith Siyambalapitiya, P. Jonsson, Maria Kołtowska‐Häggström, Rolf Christian Gaillard, Ken K. Y. Ho, Richard John M Ross · 2008 · Clinical Endocrinology
  77. Controversial Effects of Exogenous Testosterone on Cardiovascular Diseases
    Ali Al-Khazaali, Rohit Romesh Arora, Saad Muttar · 2015 · American Journal of Therapeutics
  78. Update on Testosterone Replacement Therapy in Hypogonadal Men
    Kevin M.Y.B. Leung, Khalid A. Alrabeeah, Serge Carrier · 2015 · Current Urology Reports
  79. Systemic effects of the hormonal treatment of male hypogonadism with preliminary indications for the management of COVID-19 patients
    Rossella Cannarella, Aldo Eugenio Calogero, Rosita Angela Condorelli, Antônio Aversa, Sandro La Vignera · 2020 · Therapeutic Advances in Endocrinology and Metabolism
  80. Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men
    Srikanth Krishnan, Jairo Aldana-Bitar, Ilana S. Golub, Keishi Ichikawa, Ayesha Shabir, Marziyeh Bagheri, Hossein Hamidi, Travis Benzing, Sina Kianoush, Matthew Jay Budoff · 2024 · Progress in Cardiovascular Diseases
  81. Role of Androgens in Cardiovascular Diseases in Men: A Comprehensive Review
    Dilip Mukherjee, Koushik Sen, Shreyasi Gupta, Piyali Dhar Chowdhury, Suravi Majumder, Payel Guha · 2020 · IntechOpen eBooks
  82. Low Testosterone Levels and the Risk of Metabolic Syndrome in Men
    Micol Sara Rothman, Margaret E. Wierman · 2009 · Aging Health
  83. Testosterone and cardiovascular disease
    Kevin Stephen Channer, T. Hugh Jones · 2012 · Cambridge University Press eBooks
  84. Cardiovascular benefits and risks of testosterone replacement therapy in hypogonadal men with type 2 diabetes mellitus and/or the metabolic syndrome: a systematic review
    Le Minh Quang, Atul Kalhan · 2018 · British Journal of Diabetes
  85. Hypogonadism management and cardiovascular health
    Jeremy M. Auerbach, Mohit Khera · 2020 · Postgraduate Medicine
  86. Sex Differences in Pain
    Edmund Keogh · 2008 · Springer eBooks
  87. Overweight-Related Hypertension in Middle-Aged Men Is Linked to Elevated Leptin, TNF-α, IL-6, Cholesterol, and Reduced Testosterone
    Shalan Alaamri, Abdulhalim Salim Serafi, Zahir Hussain, Shouq K. Bafail, Mohammed A. Bafail, Lusine H. Demirkhanyan, Christopher S. Gondi, Sumera Sohail · 2025 · Pathophysiology
  88. Dihydrotestosterone—a culprit in left ventricular hypertrophy
    Carolin Zwadlo, Jürgen T. Borlak · 2012 · International Journal of Cardiology
  89. Revascularization with percutaneous coronary intervention does not affect androgen status in males with chronic stable angina pectoris
    Jivendra N. Gosai, Paris Charalampidis, Theodora Nikolaidou, Yasir Parviz, Paul Morris, Kevin Stephen Channer, Thomas Hugh Jones, Ever D Grech · 2016 · Andrology
  90. Association of admission testosterone level with ST-segment resolution in male patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Ahmad Separham, Samad Ghaffari, Bahram Sohrabi, Naser Aslanabadi, Mozhgan Hadavi Bavil, Hasanali Lotfollahi · 2017 · Basic and Clinical Andrology
  91. Sexual motivation: problem solved and new problems introduced
    Donald W. Pfaff, Farid Saad · 2020 · Hormone Molecular Biology and Clinical Investigation
  92. Testosterone in men with hypogonadism and high cardiovascular risk, Pros
    Giuseppe M.C. Rosano, Cristiana Vitale, Massimo Fini · 2015 · Endocrine
  93. Is testosterone treatment dangerous for the cardiovascular system in older hypogonadal men?
    Antônio Aversa, Davide Francomano, Andrea Lenzi · 2014 · IJC Metabolic & Endocrine
  94. Testosterone Replacement Therapy in Men Aged 50 and Above: A Narrative Review of Evidence-Based Benefits, Safety Considerations, and Clinical Recommendations
    Luis Miguel Canal de Velasco, José Emiliano González Flores, Jose L Morales Arteaga · 2025 · Cureus
  95. Testosterone deficiency and treatments: common misconceptions and practical guidance for patient care
    M Khera, JamesM Hotaling, Martin M. Miner · 2025 · Sexual Medicine Reviews
  96. Testosterone and Cardiovascular Disease in Men
    Micol Sara Rothman, Margaret E. Wierman · 2007 · Aging Health
  97. Reposição hormonal e exercício físico no tratamento da insuficiência cardíaca: revisão sistemática
    Tales de Carvalho, Lourenço Sampaio de Mara, Anderson Zampiér Ulbrich · 2011 · Revista Brasileira de Medicina do Esporte
  98. Advances in small-molecule therapy for managing angina pectoris in the elderly
    Nida Waheed, Ahmad Mahmoud, Cecil A. Rambarat, Carl J. Pepine · 2019 · Expert Opinion on Pharmacotherapy
  99. The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
    Cheng‐Hung Chiang, Wan-Ting Hung, En‐Shao Liu, Tse-Hsuan Yang, Chin-Chang Cheng, Wei‐Chun Huang, Guang-Yuan Mar, Feng Yu Kuo · 2022 · Frontiers in Cardiovascular Medicine
  100. A potential relationship between diffuse musculoskeletal pain and hypogonadism
    J. K Anderson, Rebecca S. Tuetken, Valerie L. Forman‐Hoffman · 2010 · BMJ Case Reports